Optos Receives 2007 Scotland Plc Award for Innovation

LONDON, UK,– Optos plc (LSE: OPTS), a leading medical technology company for the design, development, manufacturing and marketing of retinal imaging devices, has received the 2007 Scotland plc Award for Innovation. The Award, sponsored by Oracle, recognises the efforts of companies in the identification, development and launch of new concepts capable of enhancing business performance, with a focus on how the innovation has contributed to company business performance.

Optos received the Award for successfully developing and commercialising proprietary technology that produces a digital ultra wide-field image of up to approximately 82% of the retina, compared to conventional examination techniques which can produce upwards of 5% in a single capture. The technology assists healthcare practitioners in the early detection and diagnosis of both eye and non-eye disease, which often first exhibits in the periphery of the retina.

“We are extremely honoured to receive this award because innovation is fundamental to our Company and to the success of the global economy,” said Thomas W. Butts, Chief Executive Officer, Optos plc. “By offering healthcare professionals enhanced diagnostic, monitoring and treatment capabilities, we are supporting them in delivering a higher standard of care to their patients - this can help save sight and save lives.”

The judging panel, chaired by David Thorburn, Chief Operating Officer of Clydesdale Bank plc, selected Optos from a shortlist of companies based on material provided by the research sponsor, the University of Strathclyde Business School.